GLP-1 medications can be effective for weight loss and diabetes management but require lifestyle changes and can have severe ...

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...

An investigational GLP-1 receptor agonist pill edged out oral semaglutide (Rybelsus) for improving blood glucose in adults with type 2 diabetes inadequately controlled on metformi ...

In this video, Melissa Shoemaker, MD, MPH, compares oral GLP-1 medication to previous anti-obesity treatments.

Oral Wegovy reshapes GLP-1 costs: cash pay can be cheaper, insurance pricing often matches shots, and coverage hinges on employer benefits and coding.

A weekly injection is no longer the only way to reap the obesity management and weight loss benefits of glucagon-like peptide-1 (GLP-1) medications. One oral GLP-1 option is now approved by the U.S.

Orforglipron (LY3502970) is a small-molecule, non-peptide GLP-1RA designed for oral use. Compared to popular GLP-1RAs like semaglutide, orforglipron does not require injection or an absorption ...

In an interview with The American Journal of Managed Care®, Levin explained that for patients whose medications are covered ...

The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced Monday that its daily oral Wegovy pill is now available by prescription.

An oral GLP-1 receptor agonist, Rybelsus will be available in 7-mg and 14-mg doses. "As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new ...

GLP-1 is a peptide hormone generated from proglucagon that is secreted after meals by enteroendocrine L-cells in the distal jejunum, ileum, and colon. GLP-1 is also produced by pancreatic α-cells and ...